TALENT ABDOMINAL STENT GRAFT SYSTEM - HYDRO
Report
- Report Number
- 2953200-2010-02002
- Event Type
- Injury
- Date Received
- October 19, 2010
- Date of Event
- September 20, 2010
- Report Date
- September 20, 2010
- Manufacturer
- MEDTRONIC CARDIOVASCULAR GALWAY
- Product Code
- MIH
- PMA / PMN Number
- P070027
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SC, US
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). RESULTS: (GRAFT OCCLUSION), (NARROW AORTIC BIFURCATION), (USE OF THE DEVICE TO TREAT AN ILIAC ANEURYSM WITHOUT AN ABDOMINAL AORTIC ANEURYSM). CONCLUSIONS: (NARROW AORTIC BIFURCATION), (USE OF THE DEVICE TO TREAT AN ILIAC ANEURYSM WITHOUT AN ABDOMINAL AORTIC ANEURYSM; USE OF THE DEVICE IN A NARROW AORTIC BIFURCATION).
A TALENT ABDOMINAL STENT GRAFT SYSTEM WAS IMPLANTED IN A PT FOR THE ENDOVASCULAR TREATMENT OF A 6.7 CM RIGHT ILIAC ARTERY ANEURYSM APPROX 2 MONTHS AGO. THE AORTIC BIFURCATION MEASURED 19 MM IN DIAMETER, AND THE VESSELS HAD MILD TORTUOSITY AND MILD CALCIFICATION. IT WAS REPORTED THAT APPROX 1 MONTH POST-IMPLANTATION, A FOLLOW-UP CT DEMONSTRATED THAT THERE WAS AN OCCLUSION IN THE BIFURCATED STENT GRAFT IN THE UNSUPPORTED AREA. THE PHYSICIAN ELECTED TO INTERVENE BY IMPLANTING AN ILIAC LIMB AND A BALLOON-EXPANDABLE BARE METAL STENT. HOWEVER, THE IMPLANTATION OF THE ILIAC LIMB AND BALLOON-EXPANDABLE STENT ENDED UP OCCLUDING THE CONTRALATERAL ILIAC STENT GRAFT (MFR REPORT #2953200-2010-02003). THE PHYSICIAN THEN ELECTED TO PERFORM A FEMORAL-TO-FEMORAL BYPASS, WHICH SUCCESSFULLY RESOLVED THE OCCLUSION. THE PHYSICIAN STATED THAT THE CAUSE OF THE OCCLUSION IS MOST LIKELY DUE TO THE SMALL IN DIAMETER AORTIC BIFURCATION. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED, AND THE PT IS FINE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TALENT ABDOMINAL STENT GRAFT SYSTEM - HYDRO | MIH | MEDTRONIC CARDIOVASCULAR GALWAY | NA | V00447718 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 82 YR | Required Intervention |